MENU
+Compare
TGTX
Stock ticker: NASDAQ
AS OF
Dec 4, 04:55 PM (EDT)
Price
$31.37
Change
-$0.24 (-0.76%)
Capitalization
5.02B

TGTX TG Therapeutics Forecast, Technical & Fundamental Analysis

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology
TGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TGTX with price predictions
Dec 03, 2025

TGTX in +4.31% Uptrend, rising for three consecutive days on November 26, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TGTX advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TGTX's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 03, 2025. You may want to consider a long position or call options on TGTX as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TGTX just turned positive on November 24, 2025. Looking at past instances where TGTX's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where TGTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

TGTX moved below its 50-day moving average on November 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TGTX crossed bearishly below the 50-day moving average on November 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TGTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TGTX broke above its upper Bollinger Band on November 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TGTX entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TGTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.264) is normal, around the industry mean (27.112). P/E Ratio (11.412) is within average values for comparable stocks, (52.721). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.882). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (9.606) is also within normal values, averaging (324.716).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TGTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
TGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TGTX is expected to report earnings to fall 86.54% to 32 cents per share on March 03

TG Therapeutics TGTX Stock Earnings Reports
Q4'25
Est.
$0.33
Q3'25
Beat
by $2.21
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.07
The last earnings report on November 03 showed earnings per share of $2.43, beating the estimate of 21 cents. With 403.53K shares outstanding, the current market capitalization sits at 5.02B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSPCX17.880.26
+1.48%
Emerald Growth C
ARSTX16.730.24
+1.46%
Nuveen Small Cap Select I
SCWFX75.160.53
+0.71%
American Funds SMALLCAP World F1
MSEEX24.080.06
+0.25%
Morgan Stanley Europe Opportunity C
MCFGX16.71-0.03
-0.18%
BlackRock Capital Appreciation Inv C

TGTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with KRYS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+3.20%
KRYS - TGTX
42%
Loosely correlated
+1.12%
PTCT - TGTX
37%
Loosely correlated
-3.48%
ARRY - TGTX
36%
Loosely correlated
+4.28%
CLLS - TGTX
36%
Loosely correlated
-1.06%
AXON - TGTX
36%
Loosely correlated
+1.08%
More